MTHFR and breast carcinoma: Afzal et al. and Toffili et al. reported that the MTHFR 677C>T polymorphism was associated with fluoropyrimidine-related toxicity in colorectal and breast cancer patients, respectively, without claiming a specific toxicity type [5,26].